Older heart failure patients with preserved ejection fraction (HFpEF) have severely reduced exercise capacity and quality of life. Both brachial artery fl ow-mediated dilation (FMD) and peak exercise oxygen uptake (peak VO 2 ) decline with normal aging. However, uncertainty remains regarding whether FMD is reduced beyond the degree associated with normal aging and if this contributes to reduced peak VO 2 in elderly HFpEF patients.
1
A PPROXIMATELY 50% of heart failure (HF) patients have preserved left ventricular ejection fraction (HFpEF) ( 1 ) . HFpEF is increasing in prevalence and is dominant among women and the elderly individuals ( 1 , 2 ) . The primary symptom of chronic HFpEF is exercise intolerance. We have shown that peak exercise oxygen uptake (peak VO 2 ) is as severely reduced in older HFpEF patients as in age-matched patients with HF and reduced ejection fraction (HFrEF) and is accompanied by reduced quality of life ( 3 -6 ) . We recently reported that although both cardiac output and arteriovenous oxygen difference (A-VO 2 Diff) were reduced during exercise in elderly HFpEF patients compared with age-matched healthy controls, the change in A-VO 2 Diff from rest to peak exercise was the strongest independent predictor of the reduced peak VO 2 
in HFpEF patients ( 3 ).
This fi nding regarding A-VO 2 Diff suggests that peripheral factors, such as impaired peripheral vascular and/or skeletal muscle function, play an important role in limiting exercise capacity in HFpEF ( 3 ) .
During the normal response to exercise, there is potent arterial dilation in order to increase muscle blood fl ow to meet metabolic demands and is mediated primarily by endothelial function ( 7 ) . With aging, there is a signifi cant decrease in the ability of peripheral arteries to dilate in response to stimuli, including exercise ( 8 -11 ) . Flow-mediated arterial dilation (FMD) assessed by measurement of brachial artery (BA) diameter before and after cuff occlusion with high resolution ultrasound mimics the arterial response to exercise and is an internationally standardized noninvasive index of arterial endothelial function in health and disease
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and Preserved Ejection Fraction ( 12 ) . We and others have shown that there is progressive reduction of BAFMD with normal healthy aging , and this occurs in tandem with the normal age-related decline in exercise capacity ( 8 , 11 , 13 , 14 ) . The aim of this study was to assess BAFMD and peak VO 2 in older HFpEF patients in comparison to young and old healthy volunteer control participant s. We tested the hypothesis that in older HFpEF patients, BAFMD is reduced beyond the extent that occurs with normal aging and is an important contributor to their severely reduced exercise capacity.
M ethods

Participant s
As described in previous studies ( 3 , 4 , 15 , 16 ) , HFpEF patients had symptoms and signs of HF defi ned by National Health and Nutrition Examination Survey HF clinical score of 3 or more and criteria by Rich and colleagues ( 17 , 18 ) and had preserved resting systolic function (left ventricle ejection fraction ≥ 50%, and no segmental wall motion abnormalities) and no signifi cant ischemic or valvular heart disease, pulmonary disease, anemia, or other disorder that could explain the patients ' symptoms.
Normal healthy volunteers were screened and excluded if they had any chronic medical illness, were on any chronic medication, had current complaints or an abnormal physical examination (including blood pressure ≥ 140/90 mmHg), had abnormal results on the screening tests (electrocardiogram, exercise echocardiogram, and spirometry), or were regularly exercising ( 4 , 6 ) .
Because of the profound infl uence of atherosclerosis on endothelial function and FMD ( 19 , 20 ) , patients and healthy volunteers were screened to exclude those at high risk (hyperlipidemia, cigarette smoking) and those with known or suspected coronary, cerebrovascular, and peripheral arterial disease by record review, history, physical examination, exercise echocardiography, and carotid ultrasound.
Study Protocol
The protocol was approved by the Institutional Review Board , and informed consent was obtained. During a single visit, the outcome measures of peak VO 2 and BAFMD were obtained. All tests were performed by and results analyzed by individuals blinded to patient group.
Echocardiography
Echocardiograms were performed as previously described ( 3 , 4 ) using a Hewlett-Packard model Sonos 5500 (Palo Alto, CA) ultrasound imaging system. Standard twod imensional images and Doppler were obtained and analyzed using a digital workstation as previously described ( 3 , 4 , 15 , 16 ) .
Cardiopulmonary E xercise T esting
As previously described ( 3 , 4 , 15 , 16 , 21 , 22 ) , exercise testing was performed on an electronically braked upright stationary bicycle. Expired gas analysis was conducted using a metabolic cart (CPX 2000, MedGraphics, Minneapolis, MN) , which was calibrated before each test. The initial workload was 12.5 watts for 2 min utes , followed by 25 watts for 3 min utes , and advanced thereafter by 25 watts increments in 3-minute stages. Peak O 2 consumption and CO 2 values were averaged from the fi nal 30 sec onds of the exercise test. A 6-minute -walk test was also performed ( 23 ) .
Brachial A rtery F low-M ediated D ilation
With participants in the postprandial state and resting quietly in the supine position, BAFMD was measured as previously described in our laboratory according to international standards ( 8 , 12 , 24 -26 ) . A cuff was placed on the right forearm below the antecubital fossa. Using a Biosound Phase II ultrasound system, images of the brachial artery at baseline were recorded. The cuff was then infl ated to 50mm Hg above systolic pressure for 4 min utes . Images were recorded during the fi nal 30 seconds prior to and 3 minutes following rapid cuff defl ation ( 8 ) . Video frames were automatically digitized and analyzed using previously described techniques ( 8 ) . To quantify the vasodilator response, the average diameter of the brachial artery was recorded from the fi nal 30 seconds of the baseline scanning period. The maximum diameter from the dilation phase was automatically determined, and the change in diameter and percent change were calculated. We have previously reported the reproducibility of FMD using these techniques in over 4,000 patients in our laboratory ( 8 ) .
Statistical Analysis
Comparisons were performed using analysis of covariance adjusting for age, gender, and body surface area unless otherwise noted. Intergroup comparisons of baseline characteristics, exercise performance, and brachial artery imaging were made using the global F -test for continuous measures and Fisher ' s exact test for categorical measures. Multiple linear regression analysis was performed to determine signifi cant predictors of peak VO 2 and to determine the independent effects of these variables on peak VO 2 . A two-tailed p value of <.05 was required for signifi cance. Values are expressed as means ± SD unless otherwise noted. The Statistical Analysis Software program (SAS) was used for all analyses.
R esults
Participant C haracteristics
The HFpEF participant s and older healthy controls were well matched for age and gender. The HFpEF participant s were predominantly older women with a history of hypertension ( Table 1 ) . HFpEF patients were stable, New York Heart Association class II and III. Compared with age-matched healthy controls, they had hypertrophic left ventricle remodeling, left atrial dilation , and abnormal diastolic fi lling, all typical characteristics of HFpEF ( Table 2 ) .
Peak E xercise O xygen C onsumption
Peak respiratory exchange ratio was greater than 1.12 in all groups, indicating an exhaustive level of exercise effort. Note: HFpEF = heart failure with preserved ejection fraction; OH = older healthy control participant s . Data presented as mean ± SD .
Peak VO 2 was signifi cantly reduced in HFpEF patients compared with healthy older and younger controls (15.2 ± 0.5 vs 19.6 ± 0.6 vs 28.5 ± 0.8 m L /kg/min, all comparisons p < .0001). Peak VO 2 was also reduced in healthy older versus younger controls ( Table 3 ). Exercise time, peak power output, heart rate, carbon dioxide production, and oxygen pulse were signifi cantly reduced in HFpEF compared with healthy older and younger healthy controls and in older compared with younger healthy control groups ( Table 3 ). The 6-minutewalk distance was signifi cantly reduced in HFpEF patients compared with healthy older controls and between healthy younger and older participant s ( Table 3 ) .
Brachial A rtery F low-M ediated D ilation
BAFMD was signifi cantly reduced in healthy older compared with healthy young control participant s. However, BAFMD was not signifi cantly different in HFpEF patients compared with healthy age-matched older controls ( Table 4 , Figure 1 ). The absolute change in brachial artery diameter was reduced in older compared with healthy young control participant s, but was also not different in HFpEF patients compared with healthy older controls ( Table 4 ) . Both baseline and maximum brachial artery diameter were greater in the HFpEF patients compared with healthy older participant s ( Table 4 ) .
Relationship of BAFMD and P eak VO 2
In univariate analyses, BAFMD was modestly related to peak VO 2 ( r = .19; p = .048; Table 5 ), and age and gender were strongly related to peak VO 2 (age r = − .68; p < .001; gender r = .89; p < .001). In a multivariate model, after adjustment for age, gender, and body surface area, there was no signifi cant relationship between BAFMD and peak VO 2 ( r = .009; p = .93; Table 5 ). In addition, neither baseline nor maximum brachial artery diameter showed a signifi cant independent relationship to peak VO 2 ( Table 5 ). These results were unchanged when adjustments were made to account for medications.
D iscussion
Although many studies have examined the mechanisms of exercise intolerance in HFrEF ( 27 -29 ) , in HFpEF the mechanisms of exercise intolerance are not well understood ( 30 ) , even though the predominantly elderly patients with this disorder represent a large and increasing proportion of the HF population ( 1 , 2 ). As anticipated, the HFpEF patients had severely reduced peak VO 2 compared with age-matched healthy participant s, in accord with our prior reports in separate groups of patients ( 3 -5 , 22 ) . BAFMD was greatly reduced in healthy persons 60 y ea rs or older compared with those 30 y ea rs or younger . This is consistent with prior studies in our laboratory and others that have shown a progressive decline in BAFMD with advancing age in healthy volunteers ( 8 , 11 , 13 , 14 ) . However, elderly patients with HFpEF did not have reduced BAFMD compared with healthy age-matched peers. Although BAFMD had a modest univariate relationship with peak exercise VO 2 , there was no signifi cant independent relationship after taking into consideration age, gender, and body size. These data suggest that FMD is not abnormal in older patients with HFpEF and does not signifi cantly contribute to their severely reduced exercise capacity.
These fi ndings are important because understanding mechanisms of exercise intolerance can provide insights into pathophysiology and potential treatment of this common and important disorder ( 30 ) . Our results suggest that the decreased peak exercise A-VO 2 Diff in HFpEF patients is not due to reduced large artery vasodilatory reserve function. This further suggests that other peripheral factors, such as impaired skeletal muscle function resulting in reduced oxygen utilization by the active muscle, may play an important role in the reduced exercise capacity in elderly HFpEF patients.
We addressed FMD as a potential mechanism for our recently reported fi nding of reduced peak A-VO 2 Diff in HFpEF because studies in HFrEF patients indicated that reduced vasodilator reserve contributes to exercise intolerance in those patients ( 29 , 31 ) . Hornig and colleagues ( 31 ) reported that BAFMD was severely reduced in HFrEF patients, correlated with the reduced exercise capacity, and improved with exercise training along with peak VO 2 . Our fi ndings suggest that although HFpEF patients have reductions in peak VO 2 that are just as severe as in HFrEF patients, the contributing mechanisms may differ somewhat. The implications of our fi ndings, which point to the potential role of skeletal muscle abnormalities in HFpEF, are supported by a number of studies in healthy elderly individuals and HFrEF Notes: YH = young healthy control participant s; OH = older healthy control participant s; HFpEF = Heart failure and preserved ejection fraction patients . Data presented as mean ± SE after adjustment for gender and body surface area .
* Data also adjusted for baseline diameter. Note: YH = young healthy control participant s; OH = older healthy control participant s; HFpEF = Heart failure and preserved ejection fraction; HR = heart rate; SBP = systolic blood pressure; DBP = diastolic blood pressure; VO 2 = oxygen consumption; O 2 P = oxygen pulse; VCO 2 = carbon dioxide production; RER = respiratory exchange ratio; 6MWD = 6 -min walk distance. Data presented as mean ± SE following adjustment for gender and body surface area.
patients that indicate that skeletal muscle function is markedly abnormal, contributes to exercise intolerance, and may improve with exercise training ( 5 , 32 -35 ) .
Using phase-contrast magnetic resonance imaging we previously reported that femoral artery FMD was significantly reduced in elderly HFrEF patients compared with age-matched healthy volunteer participant s and HFpEF patients ( 6 ) . However, femoral artery FMD was relatively preserved in elderly HFpEF patients and was similar to the age-matched healthy control participant s ( 6 ). The present report signifi cantly extends these prior fi ndings by utilizing high resolution ultrasound of brachial artery FMD in a much larger number of elderly HFpEF patients and agematched healthy control participant s, both of which were well screened to exclude the confounding infl uence of atherosclerosis, and also by adding a group of young healthy control participant s. This allowed us to demonstrate the expected age-related decline in FMD and show that HFpEF patients had no further decline in FMD beyond that due to age alone. Furthermore, the present study examined FMD in a different arterial bed, using techniques that are standardized and well accepted. Taken together, our studies support that abnormal FMD is not a significant contributor to the severely reduced exercise capacity in HFpEF patients ( 6 ) .
Because of the known profound impact of atherosclerosis on endothelial function and FMD ( 19 , 20 ) , our study design included screening for coronary, cerebrovascular, and peripheral vascular disease as described above in both HFpEF patients and healthy older control participant s. This is a strength of the present study, as the confounding infl uence of atherosclerosis has not been uniformly accounted for in prior studies of FMD. Manifest atherosclerotic disease, particularly concomitant ischemic heart disease, is more common in HFrEF than HFpEF ( 1 , 36 ) . However , multiple prior studies using animal models and carefully selected patient groups have shown that abnormal endothelial function is present in both brachial and femoral arterial beds in HFrEF, even in the absence of atherosclerosis ( 37 -39 ) . Taken together with our data, this suggests that abnormal FMD is a fundamental component of the pathophysiology of HFrEF but not HFpEF.
Using an automated fi nger tonometry assessment technique, Borlaug and colleagues ( 40 ) recently reported that fi nger blood fl ow was reduced in elderly HFpEF patients compared with age-matched healthy control participant s but was not different in HFpEF patients compared with hypertensive control participant s without HF. This supports that abnormal FMD is not a unique aspect of HFpEF pathophysiology apart from concomitant disease, such as hypertension which is present in about 90% of HFpEF patients ( 1 ) . The disparity between study fi ndings may be attributable to differences in patient characteristics and methodology. In our study, we excluded participant s with known atherosclerosis. In contrast, one third of the elderly HFpEF patients in the Borlaug study had known, clinically signifi cant underlying coronary artery disease, and information regarding hyperlipidemia, carotid, cerebrovascular , and peripheral arterial disease was not reported. We assessed endothelial function using high resolution ultrasound in response to cuff ischemia which refl ects large conduit artery vasodilation. It is an internationally standardized well-accepted technique shown by our group and others to be related to clinical outcomes ( 25 , 26 ) and is sensitive to changes after therapy ( 8 , 31 ) . Borlaug and colleagues on the other hand assessed the change in fi nger pulse amplitude in response to cuff ischemia , which is a newer technique that is thought to ( 30 , 31 , 42 , 43 ) . All groups of participant s in the present study were sedentary and not involved in regular exercise, suggesting that this potential confounding factor was not primarily responsible for our results.
Limitations
For ethical reasons, cardiac medications were withheld for only 12 hours before exercise testing and brachial artery imaging in patients. However, the overall results were unchanged after adjustments to take cardiovascular-active medications into account.
This study assessed FMD in the brachial artery ; however, the primary working muscle beds during upright cycle exercise are in the lower limb and are supplied primarily by the femoral artery. However, as discussed above, we have reported that femoral artery FMD is similar between elderly HFpEF patients and age-matched healthy participant s despite marked differences in peak VO 2 ( 6 ) .
Our HFpEF patients were predominantly women, refl ecting the sex distribution found in population studies ( 1 ). Celermajer reported that FMD is reduced in men compared with women ( 13 ). However, there was no difference in sex distribution between our HFpEF patients and age-matched controls, and results were unchanged after adjustment for sex.
C onclusion
Elderly HFpEF patients had severely decreased exercise capacity compared with age-matched healthy participant s ( 3 -5 , 22 ) , and BAFMD was greatly reduced in healthy older versus younger individuals ; however, elderly HFpEF patients did not have reduced brachial artery FMD compared with healthy age-matched controls. Further, BAFMD did not have a signifi cant independent relationship to peak VO 2 in these patients. This suggests that peripheral arterial endothelial dysfunction may not be a primary signifi cant contributor to reduced exercise capacity in HFpEF. This suggests that future studies should examine other factors including skeletal muscle function in elderly HFpEF patients and their potential contribution to exercise intolerance, the primary chronic symptom in the large and growing number of patients with this syndrome.
